---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-067081"
form_type: "8-K"
ticker: "MOVE"
cik: "0001734750"
company_name: "Corvex, Inc."
filed_at: "2023-08-14T23:59:59+00:00"
generated_at: "2026-06-11T11:52:22.769134+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Movano Health reports Q2 net loss $7.3M; Evie Ring launch planned before Black Friday 2023

## Summary
- Net loss $7.3M ($0.17 per share) vs $6.9M loss ($0.21 per share) in Q2 2022; no revenue.
- Cash $14.5M at June 30, 2023, up from $10.8M at year-end 2022; raised $9.2M in public offering.
- FDA 510(k) for Evie Ring pulse oximeter under full review; launch expected before Black Friday 2023.
- Over 600,000 website visitors YTD and 100,000 sign-ups for Evie Ring updates.
- Beta partners include global athletic apparel, major health insurer, and remote patient monitoring company.

## SEC filing metadata
- accession: 0001213900-23-067081
- form_type: 8-K
- ticker: MOVE
- cik: 0001734750
- company_name: Corvex, Inc.
- filed_at: 2023-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1734750/000121390023067081/0001213900-23-067081-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1734750/000121390023067081/ea183275-8k_movano.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-067081
- JSON: https://secwatch.observer/filing/0001213900-23-067081.json
- Plain text: https://secwatch.observer/filing/0001213900-23-067081.txt

## Key facts
- Earnings Releases
  Corvex, Inc. reported three months ending June 30, 2023 results: net income $7.3 million, EPS $(0.17) per basic and diluted share.
  - Period: three months ending June 30, 2023
  - Net income: $7.3 million
  - EPS: $(0.17) per basic and diluted share
  - Result: reported results
  source text: Movano Health reported a net loss of $7.3 million and a loss of $(0.17) per basic and diluted share, in the second quarter of 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1734750/000121390023067081/0001213900-23-067081-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.